Boswellia 400 mg

Boswellia 400 mg

Swanson4.7 (2,325 ratings)
Format:Capsule Quantity: 100 Capsule(s) · 50 servings
Goals
$12.09 $0.24 per serving
iHerbLowest$12.09iHerb$12.09Amazon$15.19

About this product

Two capsules provide 800 mg of Boswellia serrata, despite the product name highlighting a per-capsule amount. The total serving is substantial and keeps the formula focused on one botanical.

No extract ratio, total boswellic-acid percentage, or AKBA content is listed. Raw herb can vary in active-compound concentration, so the large milligram figure does not ensure the same delivery as a standardized extract.

The low serving cost supports budget use, but the two-capsule dose is less convenient than similar one-capsule products. It suits users who want simple raw Boswellia and understand the potency trade-off.

Who is it for
  • Adults seeking an economical raw Boswellia product
  • People comfortable taking two capsules per serving
  • Users who value simplicity over standardized potency
Best for
  • Budget-focused daily use
  • Whole-herb Boswellia supplementation
  • Simple formulas without supporting actives

Pros

  • Substantial total herb amount
  • Low ongoing cost
  • No unrelated active ingredients

Cons

  • Serving requires two capsules
  • No boswellic-acid or AKBA standardization
  • Dry capsules provide no stated absorption aid

Warnings

  • The high raw-herb serving may cause digestive upset in sensitive users.
  • Boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.
  • Stop use if the gum-resin botanical triggers rash, swelling, or other allergy symptoms.

Product analysis

76 out of 100
A large, inexpensive raw-herb dose offers simple support, with poor active-marker disclosure and no enhanced delivery.

AI assessment of the formula, label and price. How scoring works

Nutrient quality76

The large whole-herb amount is directly relevant and reaches a useful basic range. Missing active-acid standardization and absorption support make potency unpredictable.

.
Ingredient transparency75

The herb amount is disclosed without a hidden blend. Intake directions, inactive ingredients, and active-compound strength are not supplied.

.
Customer satisfaction69

The supplied average rating is strong and comes from a substantial rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.
Value for money84

The large herb amount provides fair value at a modest serving cost. Missing standardization limits quality-based competitiveness.

.
Format
Capsule
Container
100 Capsule(s)
Per serving
$0.24
Customer rating
4.7 · 2,325 ratings
Report analysis

Goals

Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Limited evidence
F Ingredient FitF PathwaysF EvidenceF Formulation Logic
Boswellia · 800 mg
Study evidence
Boswellia Supportive 19 studies
Joint Health
Joint Health
Impact
Moderate effect
A+ Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Boswellia · 800 mg
Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per servingScore
Boswellia serrata
800 mg 30
Adults 18–50
Report overview
Boswellia · 800 mg OverallScore30
F Composition And Label DisclosureC Composition And Label Disclosure
Boswellia 400 mg provides 800 mg of Boswellia serrata per serving, but the saved details give no boswellic-acid percentage. The form and amount are clear, while the marker amount remains unknown. No Boswellia-specific price comparison is provided.
How this ingredient is rated

Composition and Label Disclosure0

The saved details identify Boswellia serrata but give no boswellic-acid percentage.
Marker and Preparation Disclosure
Boswellia serrata is named, but no boswellic-acid percentage is recorded.

Composition and Label Disclosure60

The serving amount is known, but the saved information gives no marker percentage.
Boswellia Amount and Marker Disclosure
The saved details state 800 mg of Boswellia, but no marker percentage.

Commercial Price and Usability

No Boswellia-specific price comparison is provided here.
View ingredientView products
Loading alternative details
83 Performance

Boswellia AKBA

Pure Encapsulations

For a stronger ingredient and goal fit, a recognized 5-LOXIN extract provides a focused high-AKBA Boswellia source at a practical amount. Compared with the original, it remains a focused Boswellia option; efficient serving value offsets the absence of an explicit active-acid percentage and separate absorption aid.

84 Performance

Boswellia Extract 500 mg

California Gold Nutrition

For a stronger ingredient and goal fit, a substantial branded boswellia extract and concentrated turmeric create strong joint-focused coverage. Compared with the original, it remains a focused Boswellia option; boswellic-acid and curcuminoid percentages remain partly unclear.

82 Performance

Boswellia 400 mg

Nature's Answer

For a stronger ingredient and goal fit, a focused 400 mg Boswellia extract offers a practical amount and favorable serving value. Compared with the original, it remains a focused Boswellia option; missing boswellic-acid strength and lack of absorption support keep the quality basic.

81 Budget

Boswellia Extract 600 mg

Herbal Secrets

At a lower serving cost than the original, a focused Boswellia extract supplies a substantial amount at an efficient serving cost. Compared with the original, it remains a focused Boswellia option; missing boswellic-acid and AKBA percentages limit confidence in potency, and no enhanced delivery method is identified.

81 Budget

Boswellia Extract 500 mg

NOW

At a lower serving cost than the original, a substantial Boswellia amount, lipid delivery, and low serving cost create strong basic value, though active-acid percentages remain unclear. Compared with the original, it remains a focused Boswellia option; boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.

81 Budget

Boswellia Serrata

Swanson

At a lower serving cost than the original, a substantial combination of whole Boswellia and a named extract provides focused support and strong value, though active-acid percentages are absent. Compared with the original, it remains a focused Boswellia option; boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.

79 Value

Boswellia Extract

SuperiorLabs

For a more favorable quality-to-cost balance, a substantial frankincense extract with black pepper creates a focused inflammation and joint-support formula at a favorable recurring cost. Compared with the original, it remains a focused Boswellia option; missing boswellic-acid and AKBA percentages limit potency comparison, while the small leucine amount adds little independent value.

79 Value

Boswellia Serrata Extract 125 mg

Swanson Ultra

For a more favorable quality-to-cost balance, a practical amount of a specialized high-AKBA Boswellia extract creates a focused formula with good value, though the active percentage is not stated. Compared with the original, it remains a focused Boswellia option; boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.

78 Value

Boswellia Resin Extract

Solgar

For a more favorable quality-to-cost balance, a substantial extract-plus-powder serving provides focused Boswellia support and good basic value, though active-acid percentages are missing. Compared with the original, it remains a focused Boswellia option; boswellia may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support forBoswellia
  3. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  4. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsAnti-Inflammatory Support Joint Health forBoswellia
  5. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsAnti-Inflammatory Support Joint Health forBoswellia
  6. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  7. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  8. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia